RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Brazil: New Manual For Labeling National Health Service Drugs

Brazil: New Manual For Labeling National Health Service Drugs

Posted 02 April 2012 | By Ansis Helmanis

A new manual for medicines intended for use by Brazil's National Health Service (NHS) has been prepared by the country's national regulatory agency, ANVISA. The Manual requires the labeling of such drugs to carry the non-proprietary name of the drug and to have the NHS seal on all drug packaging, blister packs, vials, and bottles. The labeling requirements are intended to encourage NHS medical professionals to prescribe using the generic name of the active ingredient of the product, rather than the brand name.


Read more:

Anvisa lança manual para rotulagem dos medicamentos do Ministério da Saúde

 

© 2022 Regulatory Affairs Professionals Society.